Nailfold videocapillaroscopy micro-haemorrhage and giant capillary counting as an accurate approach for a steady state definition of disease activity in systemic sclerosis

Arthritis Research and Therapy

Volumn 16, Issue 1, 2014, Pages

  Sambataro, Domenico ^a   Sambataro, Gianluca ^a   Zaccara, Eleonora ^a   Maglione, Wanda ^a   Polosa, Riccardo ^b   Afeltra, Antonella M V ^c   Vitali, Claudio ^d   del Papa, Nicoletta ^a  

^a Ospedale Gaetano Pini Milan   (Italy)

^b UNIVERSITY OF CATANIA   (Italy)

^c Policlinico Universitario Campus Bio Medico di Roma ^*  (Italy)

^d Instituto San Giuseppe   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; AREA UNDER THE CURVE; ARTICLE; CAPILLAROSCOPY; COHORT ANALYSIS; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DISEASE COURSE; EUROPEAN SCLERODERMA STUDY GROUP INDEX; FEMALE; GIANT CAPILLARY COUNTING; GOLD STANDARD; HUMAN; MAJOR CLINICAL STUDY; MALE; NAILFOLD VIDEOCAPILLAROSCOPY; NUMBER OF MICROHEMORRHAGE; PHYSICAL PARAMETERS; RECEIVER OPERATING CHARACTERISTIC; SCLERODERMA DISEASE ACTIVITY INDEX; SENSITIVITY AND SPECIFICITY; SYSTEMIC SCLEROSIS; ADOLESCENT; ANGIOSCOPY; BLEEDING; CAPILLARY; FINGER; MIDDLE AGED; PATHOLOGY; PATHOPHYSIOLOGY; PROCEDURES; REPRODUCIBILITY; SEVERITY OF ILLNESS INDEX; STATISTICAL MODEL; VASCULARIZATION; VERY ELDERLY; VIDEO MICROSCOPY; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; CAPILLARIES; FEMALE; FINGERS; HEMORRHAGE; HUMANS; LOGISTIC MODELS; MALE; MICROSCOPIC ANGIOSCOPY; MICROSCOPY, VIDEO; MIDDLE AGED; REPRODUCIBILITY OF RESULTS; SCLERODERMA, SYSTEMIC; SEVERITY OF ILLNESS INDEX; YOUNG ADULT;

EID: 84988848303     PISSN: 14786354     EISSN: 14786362     Source Type: Journal    
DOI: 10.1186/s13075-014-0462-8     Document Type: Article

References (30)

1. LeRoy EC, Black C, Fleischmajer R, Jablonska S, Krieg T, Medsger TA Jr, Rowell N, Wollheim F: Scleroderma (systemic sclerosis): classification, subsets and pathogenesis. J Rheumatol 1988, 15:202-205.
2. Kahaleh B: The microvascular endothelium in scleroderma. Rheumatology (Oxford) 2008, 47:14-15.
3. Gabrielli A, Avvendimento EV, Krieg T: Scleroderma. N Eng J Med 2009, 360:1989-2003.
4. Del Papa N, Colombo G, Fracchiolla N, Mazzeo Moronetti L, Ingegnoli F, Maglione W, Comina DP, Vitali C, Fantini F, Cortellezzi A: Circulating endothelial cells as a marker of ongoing vascular disease in systemic sclerosis. Arthritis Rheumatol 2004, 50:1296-1304.
5. Nadashkevich O, Davis P, Fritzler M, Kovalenko W: A randomized unblinded trial of cyclophosphamide versus azathioprine in the treatment of systemic sclerosis. Clin Rheumatol 2006, 25:205-212.
6. Matucci-Cerinic M, Allanore Y, Czirják L, Tyndall A, Müller-Ladner U, Denton C, Valentini G, Distler O, Fligelstone K, Tyrrel-Kennedy A, Farge D, Kowal-Bielecka O, van den Hoogen F, Cutolo M, Sampaio-Barros PD, Nash P, Takehara K, Furst DE: The challenge of early systemic sclerosis for the EULAR Scleroderma Trial and Research group (EUSTAR) community. It is time to cut the Gordian knot and develop a prevention or rescue strategy. Ann Rheum Dis 2009, 68:1377-1380.
7. Stratton RJ, Wilson H, Black CM: Pilot study of anti-thymocyte globulin plus mycophenolate mofetil in recent-onset diffuse scleroderma. Rheumatology (Oxford) 2001, 40:84-88.
8. Valentini G, Della Rossa A, Bombardieri S, Bencivelli W, Silman AJ, D'Angelo S, Cerinic MM, Belch JF, Black CM, Bruhlman P, Czirjak L, De Luca A, Drosos AA, Ferri C, Gabrielli A, Giacomelli R, Hayem G, Inanc M, McHugh NJ, Nielsen H, Rosada M, Scorza R, Stork J, Sysa A, van den Hoogen FH, Vlachoyiannopoulos P: European multicentre study to define disease activity criteria for systemic sclerosis. II. Identification of disease activity variables and development of preliminary activity indexes. Ann Rheum Dis 2001, 60:592-598.
9. Valentini G, Bencivelli W, Bombardieri S, D'Angelo S, Della Rossa A, Silman AJ, Black CM, Czirjak L, Nielsen H, Vlachoyiannopoulos PG: European multicentre study to define disease activity criteria for systemic sclerosis. III. Assessment of the construct validity of the preliminary activity criteria. Ann Rheum Dis 2003, 62:901-903.
10. Cutolo M, Pizzorni C, Secchi ME, Sulli A: Capillaroscopy. Best Pract Res Clin Rheumatol 2008, 22:1093-1108.
11. Van den Hoogen F, Khanna D, Fransen J, Johnson SR, Baron M, Tyndall A, Matucci-Cerinic M, Naden RP, Medsger TA Jr, Carreira PE, Riemekasten G, Clements PJ, Denton CP, Distler O, Allanore Y, Furst DE, Gabrielli A, Mayes MD, van Laar JM, Seibold JR, Czirjak L, Steen VD, Inanc M, Kowal-Bielecka O, Muller-Ladner U, Valentini G, Veale DJ, Vonk MC, Walker UA, Chung L, et al: 2013 Classification criteria for systemic sclerosis. An American College of Rheumatology/European League Against Rheumatism Collaborative Initiative. Arthritis Rheumatol 2013, 65:2737-2747.
12. Ingegnoli F, Boracchi P, Gualtierotti R, Lubatti C, Meani L, Zahalkova L, Zeni S, Fantini F: Prognostic model based on nailfold capillaroscopy for identifying Raynaud's phenomenon patients at high risk for the development of a scleroderma spectrum disorder. Arthritis Rheumatol 2008, 58:2174-2182.
13. Sulli A, Secchi ME, Pizzorni C, Cutolo M: Scoring the nailfold microvascular changes during the capillaroscopic analysis in systemic sclerosis patients. Ann Rheum Dis 2008, 67:885-887.
14. Corrado A, Carpagnano GE, Gaudio A, Foschino-Barbaro MP, Cantatore FP: Nailfold capillaroscopic findings in systemic sclerosis related lung fibrosis and in idiopathic lung fibrosis. Joint Bone Spine 2010, 77:570-574.
15. Cutolo M, Sulli A, Pizzorni C, Accardo S: Nailfold videocapillaroscopy assessment of microvascular damage in systemic sclerosis. J Rheumatol 2000, 27:155-160.
16. Wong ML, Highton J, Palmer DG: Sequential nailfold capillary microscopy in scleroderma and related disorders. Ann Rheum Dis 1988, 47:53-61.
17. Cutolo M, Sulli A, Smith V: How to perform and interpret capillaroscopy. Best Pract Res Clin Rheumatol 2013, 27:237-248.
18. Zufferey P, Depairon M, Chamot AM, Monti M: Prognostic significance of nailfold capillary microscopy in patients with Raynaud's phenomenon and scleroderma-pattern abnormalities. A six-year follow-up study. Clin Rheumatol 1992, 11:536-541.
19. Grassi W, Del Medico P: Microbleeding and capillary thrombosis. In Atlas of Capillaroscopy. Grassi and Del Medico: EDRA, Medical Publishing & New Media, Milan; 2004:122-130.
20. Valentini G: The assessment of the patient with systemic sclerosis. Autoimmun Rev 2003, 2:370-376.
21. Clements PJ, Lachenbrunch PA, Seibold JR, Zee B, Steen VD, Brennan P, Silman AJ, Allegar N, Varga J, Massa M, Wigley FM, Ingenito F, Weisman M, White B, Martin RW, McCloskey D, Moreland LW, Mayes M, Lally EV, Unanue M, Cottier DH, Weiner S, Weinstein A, Medsger TA, Andrews B, Dixon M, Furst DE: Skin thickness score in systemic sclerosis: an assessment of interobserver variability in 3 independent studies. J Rheumatol 1993, 20:1892-1896.
22. Furst DE, Clements PJ, Steen VD, Medsger TA Jr, Masi AT, D'Angelo WA, Lachenbrunch PA, Grau RG, Seibold JR: The modified Rodnan skin score is an accurate reflection of skin biopsy thickness in systemic sclerosis. J Rheumatol 1998, 25:84-88.
23. Olski TM, Hunzelmann N, Krieg T: The skin in systemic scleroderma. In The Skin in Systemic Autoimmune Diseases, Volume 5. Edited by Sarzi-Puttini, Doria, Girolomoni, Kuhn. London: Elsevier; 2006:119-133.
24. De Angelis R, Grassi W, Cutolo M: A growing need for capillaroscopy in rheumatology. Arthritis Rheum 2009, 61:405-410.
25. Smith V, Decuman S, Sulli A, Bonroy C, Piettte Y, Deschepper E, de Keyser F, Cutolo M: Do worsening scleroderma capillaroscopic patterns predict future severe organ involvement? A pilot study. Ann Rheum Dis 2012, 71:1636-1639.
26. Sebastiani M, Manfredi A, Lo Monaco A, Praino E, Riccieri V, Grattagliano V, Bortoluzzi A, Stefanantoni K, D'Amico R, Giuggioli D, Ferri C: Capillaroscopic Skin Ulcers Risk Index (CSURI) calculated with different videocapillaroscopy devices: how its predictive values change. Clin Exp Rheumatol 2013, 31:115-117.
27. Tektonidou M, Kaskani E, Skopouli N, Moutsopoulos HM: Microvascular abnormalities in Sjögren's syndrome: nailfold capillaroscopy. Rheumatology (Oxford) 1999, 38:826-830.
28. Aslanidis S, Pyrpasopoulou A, Doumas M, Triantafyllou A, Chatzimichailidou S, Zamboulis C: Association of capillaroscopic microhaemorrages with clinical and immunological antiphospholipid syndrome. Clin Exp Rheumatol 2011, 29:307-309.
29. Bongard O, Bounameaux H, Miescher PA, De Moerloose P: Association of anticardiolipin antibodies and abnormal nailfold capillaroscopy in patients with systemic lupus erythematosus. Lupus 1995, 4:142-144.
30. Hosking SP, Bhatia R, Crock PA, Wright I, Squance ML, Reeves G: Non-invasive detection of the microvascular changes in a paediatric and adolescent population with type 1 diabetes: a pilot cross-sectional study. BMC Endocr Disord 2013, 13:41.